Discover 520 paid clinical trials in Madison, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 520
Active & Responsive
A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer
for
Non-Muscle Invasive Bladder Urothelial Carcinoma,
Location: Madison WI, Columbus OH, Tucson AZ
Sponsor: University of Wisconsin, Madison
Sex: Male
Age: 18+
Code: NCT05521698
Phase 1, Recruiting
Active & Responsive
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Location: Madison WI, Milwaukee WI, Iowa City IA, Rochester MN,
Sponsor: C4 Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07284758
Phase 2, Recruiting
Active & Responsive
Cognitive Impact of Neoadjuvant Chemotherapy for Gynecologic Cancers
for
Ovarian Cancer, Cognitive Change
Location: Madison WI
Sponsor: University of Wisconsin, Madison
Sex: Female
Age: 18+
Code: NCT07125209
Recruiting
Active & Responsive
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
for
Prostate Cancer,
Location: Madison WI, Evanston IL, Chicago Ridge IL,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: Male
Age: 18+
Code: NCT07005154
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
for
Pleuropulmonary Blastoma
Location: Madison WI, Green Bay WI, Chicago IL, Iowa City IA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT06647953
Phase 3, Recruiting
Active & Responsive
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
for
Acute Myeloid Leukemia
Location: Madison WI, Cincinnati OH, Memphis TN, Little Rock AR,
Sponsor: Norman J. Lacayo
Sex: All
Age: 0 - 21
Code: NCT05101551
Phase 1, Recruiting
Active & Responsive
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma